As of April 16, 2025, DBV Technologies (DBVT) has a market cap of $0.20 billion USD. According to our data, DBV Technologies is ranked No.6968 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.20 B |
217.55%
|
Dec 31, 2024 | $63.40 M |
62.12%
|
Dec 29, 2023 | $39.10 M |
-37.71%
|
Dec 30, 2022 | $62.78 M |
-4.38%
|
Dec 31, 2021 | $65.65 M |
-38.93%
|
Dec 31, 2020 | $0.11 B |
-75.51%
|
Dec 31, 2019 | $0.44 B |
66.67%
|
Dec 31, 2018 | $0.26 B |
-73.90%
|
Dec 29, 2017 | $1.01 B |
-29.97%
|
Dec 30, 2016 | $1.44 B |
-3.25%
|
Dec 31, 2015 | $1.49 B |
33.89%
|
Dec 31, 2014 | $1.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
Market Cap | = | DBVT Stock Price | * | DBVT Shares Outstanding |
= | $7.35 | * | 27.39 M | |
= | $0.20 B |